Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides

Por um escritor misterioso

Descrição

Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Cells, Free Full-Text
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression - ScienceDirect
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Antibodies, Free Full-Text
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Frontiers Applications of nanobodies in brain diseases
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Frontiers Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
The screening, identification, design and clinical application of tumor- specific neoantigens for TCR-T cells, Molecular Cancer
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics - Li - 2005 - The FASEB Journal - Wiley Online Library
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Frontiers PDL1Binder: Identifying programmed cell death ligand 1 binding peptides by incorporating next-generation phage display data and different peptide descriptors
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Innovative Diagnostic Peptide‐Based Technologies for Cancer Diagnosis: Focus on EGFR‐Targeting Peptides - Ahmadi - 2023 - ChemMedChem - Wiley Online Library
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Screening of a phage-displayed random peptide library using a protein
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Molecules, Free Full-Text
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Design, production, and purification of recombinant EGFRvIII-targeting
Identification of a novel peptide ligand for the cancer-specific receptor  mutation EGFRvIII using high-throughput sequencing of phage-selected  peptides
Cancers, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)